Why Don't Elephants Get Cancer More Often?

Run the arithmetic and an elephant should be one of the unluckiest animals on Earth. It is built from roughly a thousand trillion cells, more than thirty times the number in a human body, and every one of those cells has to copy its full genetic library each time it divides. Each copy is a chance for the DNA to be misread, and a small fraction of those misreadings are the exact mistakes that start cancer. More cells, dividing more times, across a seventy year lifespan, should add up to a near certain tumor before the animal even reaches adulthood.

The short answer

Elephants avoid the cancer their cell count predicts because they carry roughly twenty working copies of TP53, the gene that builds the tumor suppressing protein p53, compared to a single copy in humans. Those extra copies make elephant cells far quicker to detect DNA damage and destroy the damaged cell before it can turn cancerous. A second, resurrected gene called LIF6 backs up that system by killing compromised cells outright. Together they explain how the largest land animal on Earth ends up with one of the lowest cancer rates of any species studied.

The math that should doom them

Studies of zoo elephants that died of any cause put their cancer mortality at under five percent. In humans the same figure runs somewhere between eleven and twenty five percent. The animal with the most cells and one of the longest lives on land should, by simple probability, carry one of the worst cancer records in the animal kingdom. Instead it carries one of the best, which is exactly the contradiction that first caught a scientist's attention decades ago.

Peto's Paradox

In 1977 the epidemiologist Richard Peto pointed out a pattern that still surprises people the first time they hear it. Across species, body size and cancer rate show almost no relationship at all. A mouse and a whale differ in body mass by a factor of ten thousand, yet they get cancer at broadly similar rates. Common sense predicts a steep climb in cancer risk as bodies get bigger and live longer. The data shows something close to a flat line, and for decades nobody had a clean explanation for why.

Twenty copies of the guardian gene

The explanation, once researchers found it, sat inside a single gene called TP53. It builds a protein called p53, often nicknamed the guardian of the genome, because of the decision it makes inside a damaged cell. When p53 detects DNA damage, it can order the cell to pause and repair itself, or, if the damage looks dangerous enough, order the cell to destroy itself in a clean process called apoptosis. A human genome carries one copy of TP53. An elephant genome carries around twenty.

Those extra copies change how elephant cells behave under stress. Expose elephant cells to DNA-damaging conditions in a lab and they trigger apoptosis at roughly twice the rate of human cells exposed the same way. A tumor needs damaged cells that survive long enough to multiply, and an elephant's body treats a damaged cell as expendable, clearing it out early while it is still a single cell rather than the start of a mass.

A resurrected gene as a second weapon

Elephants carry a second defense that is stranger still. Scattered through their genome are the broken remains of an old gene called LIF, switched off long ago and left as genetic scrap. One of those dead copies, LIF6, has been switched back on. Biologists call genes like this zombie genes, pieces of discarded code reactivated into working order. When p53 detects damage, it can activate LIF6, and LIF6 punches holes in the damaged cell's mitochondria, the structures that power the cell, causing it to die quickly. It functions as a backup executioner, triggered directly by the same guardian system that runs the first line of defense.

Bigness and defense evolved together

None of this protection came free or by accident. These extra safeguards appeared over the same tens of millions of years in which small, dog-sized ancestors grew into six tonne giants. Getting large is dangerous at the cellular level, since more cells and more divisions mean more chances for something to go wrong, so the lineages that survived at increasing size had to evolve correspondingly fiercer protection against their own cells turning against them. Mammoths carried these same extra TP53 copies, which suggests bigness and cancer defense rose together as a single evolutionary package rather than two separate developments.

What the numbers show

• Elephants carry roughly twenty working copies of TP53, compared to one in humans.
• Cancer mortality in zoo elephants sits under five percent, versus eleven to twenty five percent in humans.
• Elephant cells trigger apoptosis at roughly twice the rate of human cells under equal DNA-damaging stress.
• Richard Peto first described the size versus cancer mismatch in 1977, and it is still called Peto's Paradox.

Glossary

TP53

The gene that builds p53, the protein responsible for detecting DNA damage and deciding whether a cell repairs itself or self-destructs.

Apoptosis

A clean, controlled process of cell self-destruction that removes a damaged cell before it can become a tumor.

Peto's Paradox

The observation that body size and cancer rate show almost no relationship across species, even though larger bodies have far more cells.

Zombie gene

A gene that was switched off over evolutionary time and later reactivated into working order, such as LIF6 in elephants.

Mitochondria

The structures inside a cell that generate its energy; LIF6 disables them to force a damaged cell to die.

Related field notes

• All Elephants field notes

Human cancer is, in a real sense, a failure of the same system elephants carry in surplus. Researchers keep studying elephant cells for exactly that reason. Elephants Decoded follows this defense system from its cellular mechanics back to the scale of the whole animal it protects.